tiprankstipranks
Trending News
More News >
Aixcrypto Holdings, Inc. (AIXC)
:AIXC
AIXC
AIxCrypto Holdings
RESEARCH TOOLSreports
Advertisement

AIxCrypto Holdings (AIXC) Price & Analysis

Compare
Followers

AIXC Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

AIXC FAQ

What was Aixcrypto Holdings, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Aixcrypto Holdings, Inc.’s market cap?
Currently, no data Available
When is Aixcrypto Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aixcrypto Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Aixcrypto Holdings, Inc. overvalued?
According to Wall Street analysts Aixcrypto Holdings, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Aixcrypto Holdings, Inc. pay dividends?
    Aixcrypto Holdings, Inc. does not currently pay dividends.
    What is Aixcrypto Holdings, Inc.’s EPS estimate?
    Aixcrypto Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Aixcrypto Holdings, Inc. have?
    Currently, no data Available
    What happened to Aixcrypto Holdings, Inc.’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Aixcrypto Holdings, Inc.?
    Currently, no hedge funds are holding shares in AIXC

    Company Description

    Aixcrypto Holdings, Inc.

    Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis